POLYGLOB solution for injection for dogs
Homologous immunoglobulin against canine distemper, parvovirosis, hepatitis, laryngotracheitis and parainfluenza
|type of preparative:||Antisera, gloubulins|
|target species animals:||Dog|
Composition - 1 ml:
- Immunoglobulinum contra febris contagiosae canis min. 160 VNA50
- Immunoglobulinum contra parvovirosis canis min. 1024 HIU
- Immunoglobulinum contra hepatitis contagiosae canis min. 160 VNA50
- Immunoglobulinum contra laryngotracheitis canis min. 160 VNA50
- Immunoglobulinum contra parainfluensis canis min. 64 HIU
Excipients: thiomersalum 0.01 %, PBS ad 1 ml
The product contains specific homologous antibodies against canine distemper, parvovirosis, hepatitis, laryngotracheitis and parainfluenza virus. After the product is administered parenterally the passive immunity is being formed, which onset rate and duration are based on the administration method and the dose applied. The product is intended for intramuscular and intravenous application.The intravenous application ensures immediate onset of the passive immunity and the highest utilization of immunoglobulins. Passively administered immunoglobulins are degraded metabolically in the organism of treated animals and their half-life ranges between 8.5 days and 10 days
Target Animal Species:
Support therapy and passive immunoprophylaxis of dogs suffering from or being endangered by distemper, parvovirosis, hepatitis, laryngotracheitis, and parainfluenza. High antibody levels enable preventing occurrence of the diseases mentioned or palliating their course. Timeliness of the product application seems to be the important factor affecting its successful use.
Repeated application of the product may cause an allergic or even anaphylactic reaction. The product is contraindicated particularly for the preventive use in sensibilized animals or in cases when the onset of allergic and anaphylactic reactions occurs during the repeated application.
No interactions with other medicaments are known. If the vaccination is performed during the period of 7 days since the product was applied for the last time the revaccination shall be performed.
Posology and method of administration: The therapeutic dose is 0.4 ml per 1 kg of the body weight of the treated animal; it should be administered daily until the health conditions show the improvement, but maximum for 5 days.
The preventive dose is 0.4 ml per 1 kg of the body weight; it should be applied repeatedly at the interval of 48 hours.
The product is intended for the intravenous and intramuscular application.
The intravenous administration incites the instantaneous onset of the passive immunity and ensures the highest accessibility level of the dosed immunoglobulins.
The repeated application of the product may induce allergic or even anaphylactic reaction.
If any anaphylactoidal reaction occurs antihistaminics (e.g. adrenalin, calcium....) shall be immediately applied.
Special precautions for use, shake the vial and temper its content at the temperature between 25 °C and 37 °C before use.
The product is not intended for food animals.
24 months; 10 hours since the first opening.
+420 517 318 598